Today: 8 June 2026
Lumentum stock drops after insider sales — what to know before the next session
14 February 2026
1 min read

Lumentum stock drops after insider sales — what to know before the next session

New York, Feb 14, 2026, 11:16 (EST) — Market shut for the day

  • Lumentum shares lost ground for the week, following a volatile two-day stretch.
  • SEC filings showed that both an executive and a director sold shares.
  • After the Presidents Day holiday, U.S. markets are set to reopen Tuesday.

Lumentum Holdings Inc (LITE.O) slumped 3.6% to end Friday at $562.74. That quick drop followed Thursday’s high of $603.83—a sharp swing that drew plenty of trader chatter.

The drop is drawing attention, given that Lumentum’s turned into a high-beta bet on data-center optics—and lately, there’s been little patience in the market. A sharp move up leaves little cushion; even standard updates can flip sentiment on this stock.

The S&P 500 inched up 0.05% Friday, the Dow ticked up 0.10%. A handful of optics stocks moved in opposite directions—Lumentum slid, nLIGHT dipped 0.29%. IPG Photonics, on the other hand, gained 2.44%, according to MarketWatch data.

Lumentum shares swung from $539.18 to $593.40 on Friday, Yahoo Finance data showed, with volume hitting roughly 5.0 million. That kind of range highlights just how unsettled traders are on the stock.

Executive Vice President Vincent Retort unloaded 45,026 shares on Feb. 12, according to a Form 4. The shares went in several trades, with weighted average prices between roughly $576 and $602 apiece. The sale was carried out under a Rule 10b5-1 plan set up Nov. 13, 2025, the filing noted. After the transactions, Retort held 102,455 shares.

A Form 4 filing revealed director Penelope Ann “Penny” Herscher unloaded 4,000 shares on Feb. 12, fetching weighted averages between $594 and $603. She listed 2,057 shares still held directly after selling, with another 39,378 tucked away in a living trust. SEC

Lumentum’s stock rallied after the company posted robust results in early February and delivered an upbeat forecast. For its fiscal second quarter, the company booked $665.5 million in revenue with non-GAAP earnings per share at $1.67. Looking ahead, Lumentum projected fiscal third-quarter revenue between $780 million and $830 million. CEO Michael Hurlston put the optical circuit switch backlog “well beyond $400 million,” citing strong demand. Optical circuit switches are used to direct light traffic within data centers; co-packaged optics bring optics nearer to chips, boosting speed and lowering power consumption. Lumentum Investor Relations

Susquehanna’s Christopher Rolland called out “dramatically better guidance” following the results, linking it to “new opportunities emerged” as the market pushes further into faster networking geared for AI-heavy data centers. Investors.com

The stock’s fast moves aren’t all upside. Should demand for cloud and AI slow down, or the company hits supply snags or timing slip-ups, shares could tumble just as quickly — particularly now that the bar’s been raised following the latest outlook.

The next move? It’s the market’s. With U.S. exchanges shuttered Monday for Presidents Day, trading resumes Tuesday. Investors will be watching for any reaction to Friday’s selloff, along with new filings or analyst notes surfacing after the long weekend.

Stock Market Today

  • Asian Shares Fall as Big Tech Slump Hits Global Markets Amid Middle East Tensions
    June 8, 2026, 9:22 AM EDT. Asian shares dropped sharply Monday following Wall Street's worst day since October, driven by a steep decline in the technology sector. South Korea's Kospi plunged 8.3%, led by a 10.2% fall in Samsung Electronics and a 7.7% drop in SK Hynix. Japan's Nikkei 225 declined 3.9%. Wall Street futures showed early gains with Nasdaq up 1.2%. Meanwhile, oil prices surged due to renewed conflict between Israel and Iran, with Brent crude rising to $94.21 a barrel after overnight strikes. The conflict, ongoing since February, continues to disrupt global energy markets and supply chains. European shares showed mixed results, with Germany's DAX down 0.4% and Britain's FTSE 100 up 0.2%. The evolving geopolitical tensions and technology sector weakness underscore global market volatility.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus
Previous Story

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

DraftKings stock price tumbles after 2026 outlook miss; what DKNG traders watch next
Next Story

DraftKings stock price tumbles after 2026 outlook miss; what DKNG traders watch next

Go toTop